Market Research Logo

Rivaroxaban Market - Size, Share, Trends, and Forecast to 2026

Rivaroxaban Market - Size, Share, Trends, and Forecast to 2026

Rivaroxaban is an anti-coagulant medication marketed under the brand name Xarelto by Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson. The report segments the rivaroxaban market based on strength of the drug, application, distribution channel, and region. The product is segmented into 10 mg, 15 mg, and 20 mg on the basis of strength and by application, it is segmented into deep venous thrombosis and pulmonary embolism. The report on rivaroxaban is intended to target the innovators and developers to provide in-depth analysis of the present market and the expected market scenario after the patent expiration. This report compiles the global rivaroxaban market overview, dynamics, opportunities, regional analysis, and market players.
Market Dynamics
Increasing clinical trials for the expansion of present indication of rivaroxaban is expected to be the key factor driving the rivaroxaban market growth over the forecast period. For instance, as per the data of clinical trials accessed on July 2018, Swiss Paraplegic Centre was evaluating rivaroxaban for cervical spinal cord injuries, with its successful entry in phase IV. The high cost of patented drug is a major factor contributing to high revenues and compound annual growth rate (CAGR). However, patent expiration of the drug in 2021 is expected to decrease the company revenues with the entry of new entrants with generic version of the drug at lower cost. The adverse effects of the drug such as risk of bleeding in patients leading to serious and fatal conditions are expected to restrain rivaroxaban market growth. Moreover, alternative therapies such as warfarin and heparin are cheaper, as compared to rivaroxaban and are expected to hamper growth of the global rivaroxaban market.
Key features of the study:

This report provides in-depth analysis of the rivaroxaban market and provides market size (US$ Million) and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global rivaroxaban market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Janssen Pharmaceuticals Inc. and Bayer AG
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion, and marketing tactics
The global rivaroxaban market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of rivaroxaban, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the rivaroxaban market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

Global Rivaroxaban Market, By Strength:

10 mg
15 mg
20 mg

Global Rivaroxaban Market, By Application:

Deep Vein Thrombosis Prophylaxis
Pulmonary Embolism

Global Rivaroxaban Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Rivaroxaban Market, By Region:

By Strength:

10 mg
15 mg
20 mg

By Application:

Deep Vein Thrombosis Prophylaxis
Pulmonary Embolism

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

U.S.
Canada

Latin America

By Strength:

10 mg
15 mg
20 mg

By Application:

Deep Vein Thrombosis Prophylaxis
Pulmonary Embolism

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Strength:

10 mg
15 mg
20 mg

By Application:

Deep Vein Thrombosis Prophylaxis
Pulmonary Embolism

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By country:

Germany
U.K.
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Strength:

10 mg
15 mg
20 mg

By Application:

Deep Vein Thrombosis Prophylaxis
Pulmonary Embolism

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Middle East

By Strength:

10 mg
15 mg
20 mg

By Application:

Deep Vein Thrombosis Prophylaxis
Pulmonary Embolism

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By country:

GCC
Israel
Rest of Middle East

Africa

By Strength:

10 mg
15 mg
20 mg

By Application:

Deep Vein Thrombosis Prophylaxis
Pulmonary Embolism

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By country:

North Africa
Central Africa
South Africa

Company Profiles

Janssen Pharmaceuticals Inc.*

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies

Bayer AG

“*” marked represents similar segmentation in other categories in the respective section.


Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Strength
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Industry Trends
Regulatory Scenario
Epidemiology
Global Rivaroxaban Market, By Product Type, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
10 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
15 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
20 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Global Rivaroxaban Market, By Application, 2016–2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Deep Vein Thrombosis Prophylaxis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Pulmonary Embolism
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Global Rivaroxaban Market, By Distribution Channel, 2016–2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Global Rivaroxaban Market, By Regions, 2016–2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
North America
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
Northern Africa
Central Africa
South Africa
Competitive Landscape
Heat Map Analysis
Company Profiles
Janssen Pharmaceuticals Inc.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Bayer AG
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Analyst Views
Section
References
Research Methodology
About Us and Sales Contact
*Browse 22 market data tables and 20 figures on “Rivaroxaban Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report